Memantine Hydrochloride recalls

Memantine Hydrochloride products have been recalled 5 times, most recently on 22 Apr 2026. The recalling company is usually The Harvard Drug Group. The most common reason is potency & assay.

Total recalls5since 2019

Last 12 months1reported

Class I00% of total

Ongoing1latest 22 Apr 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 1 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 2 40%Class III 3 60%

Why memantine hydrochloride is recalled

Potency & Assay5100%

Companies

The Harvard Drug Group360%
Lupin Pharmaceuticals240%

By year

2026120%
2020360%
2019120%

Ongoing memantine hydrochloride recalls

1 active

Reported	Class	Recall	Company	Reason	Where
22 Apr 2026Drug	CLASS II	Memantine Hydrochloride Extended-Release, Capsules, 7 mg recalledMemantine Hydrochloride	The Harvard Drug Group	Potency & Assay	Nationwide

All memantine hydrochloride recalls, newest first

5 total

Reported	Class	Recall	Company	Reason	Where
22 Apr 2026Drug	CLASS II	Memantine Hydrochloride Extended-Release, Capsules, 7 mg recalledMemantine Hydrochloride	The Harvard Drug Group	Potency & Assay	Nationwide
20 May 2020Drug	CLASS III	Memantine Hydrochloride Extended-Release Capsules recalledMemantine Hydrochloride	The Harvard Drug Group	Potency & Assay	6 states
26 Feb 2020Drug	CLASS III	Memantine Hydrochloride Extended-release Capsules, 28mg recalledMemantine Hydrochloride	The Harvard Drug Group	Potency & Assay	Nationwide
19 Feb 2020Drug	CLASS II	Memantine Hydrochloride Extended Release Capsules, 21 mg recalledMemantine Hydrochloride	Lupin Pharmaceuticals	Potency & Assay	Nationwide
25 Dec 2019Drug	CLASS III	Memantine Hydrochloride Extended-release Capsules, 28mg recalledMemantine Hydrochloride	Lupin Pharmaceuticals	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.